Table 2 Univariate associations between molecular markers and advanced prostate cancer at the time of diagnosis. Advanced cancer was defined as skeletal metastases or clinical stage ≥ T3. Predictive accuracy of each marker is given as AUC. To facilitate comparisons between markers, the odds ratios are for an increase of one-quarter of a standard deviation.

From: Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: A case-control study